Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity, and Prevents Development of Otitis Media in Mice.

Naomi ScottKelly M MartinovichCaitlyn M GranlandElke J SeppanenM Christian TjiamCamilla de GierEdison FooKirsty R ShortKeng Yih ChewAlma FulurijaDeborah H StricklandPeter C RichmondLea-Ann S Kirkham

Published in: The Journal of infectious diseases (2024)

Haemophilus haemolyticus has potential as a live biotherapeutic for prevention or early treatment of influenza and influenza-driven NTHi OM. Additional studies will deem whether these findings translate to humans and other respiratory infections.

Keyphrases

type diabetes
risk assessment
skeletal muscle
insulin resistance
respiratory tract
replacement therapy
smoking cessation